• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket

    9/21/22 6:16:48 AM ET
    $ACRX
    $AGRI
    $AIM
    $AMPE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Metal Fabrications
    Industrials
    Get the next $ACRX alert in real time by email

    Gainers

    • Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) shares rose 14.2% to $1.93 in pre-market trading. AgriFORCE recently announced the launch of un(Think) Awakened Flour.
    • Edgio, Inc. (NASDAQ:EGIO) rose 13.1% to $3.45 in pre-market trading. Edgio reported the completion of its most successful week by setting all-time traffic record.
    • Ra Medical Systems, Inc. (NYSE:RMED) rose 12.7% to $0.1601 in pre-market trading after the company reported results of its special meeting of stockholders and a 1-for-50 reverse stock split.
    • Smart for Life, Inc. (NASDAQ:SMFL) rose 12.6% to $0.5150 in pre-market trading after declining around 5% on Tuesday.
    • AMTD Digital Inc. (NYSE:HKD) rose 12.5% to $81.60 in pre-market trading after dropping 21% on Tuesday.
    • FOXO Technologies Inc. (NYSE:FOXO) rose 10.9% to $2.34 in pre-market trading after dropping over 15% on Tuesday.
    • AIM ImmunoTech Inc. (NYSE:AIM) rose 9.1% to $0.67 in pre-market trading.
    • Windtree Therapeutics, Inc. (NASDAQ:WINT) rose 9% to $0.3609 in pre-market trading. WindTree, last month, entered into a global licensing agreement for the development and commercialization of KL4 surfactant and AEROSURF.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) rose 8.8% to $20.25 in pre-market trading. Digital World Acquisition shares dropped 17% on Tuesday following an FT report suggesting investors in the SPAC are pushing for better terms in a financing package.
    • Getty Images Holdings, Inc. (NYSE:GETY) rose 7.4% to $8.90 in pre-market trading. Macquarie, on Tuesday, initiated coverage on Getty Images with a Neutral rating and announced a price target of $8.25.
    • VistaGen Therapeutics, Inc. (NASDAQ:VTGN) rose 8% to $0.1860 in pre-market trading after declining around 5% on Tuesday.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) rose 7.8% to $2.47 in pre-market trading after dropping 67% on Tuesday.
    • Paysafe Limited (NYSE:PSFE) rose 7.7% to $1.67 in pre-market trading. Paysafe disclosed a new partnership with Spreedly to offer Paysafe’s payment gateway to Spreedly’s international merchant base.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) rose 7.7% to $0.9850 in pre-market trading after surging 13% on Tuesday.

     

    Don’t forget to check out our premarket coverage here .

    Losers

    • ECMOHO Limited (NASDAQ:MOHO) fell 29.1% to $0.0822 in pre-market trading after the company said it received delisting notice from the Nasdaq.
    • SOBR Safe, Inc. (NASDAQ:SOBR) fell 24.9% to $2.29 in pre-market trading. SOBR Safe shares jumped around 233% on Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 20.5% to $1.75 in pre-market trading after jumping over 60% on Tuesday.
    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) fell 12.4% to $5.35 in pre-market trading after declining 13% on Tuesday.
    • Smith Micro Software, Inc. (NASDAQ:SMSI) shares fell 11.9% to $2.37 in pre-market trading.
    • Amprius Technologies, Inc. (NYSE:AMPX) shares fell 10.8% to $9.81 in pre-market trading after jumping 86% on Tuesday.
    • Stitch Fix, Inc. (NASDAQ:SFIX) fell 10% to $4.25 in pre-market trading as the company reported a wider-than-expected loss for its fourth quarter and issued weak Q1 sales guidance.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 9.8% to $18.75 in pre-market trading after jumping around 42% on Tuesday.
    • Fast Radius, Inc. (NASDAQ:FSRD) shares fell 8.3% to $0.4111 in pre-market trading after gaining around 7% on Tuesday.
    • bluebird bio, Inc. (NASDAQ:BLUE) fell 7.8% to $6.32 in pre-market trading. bluebird bio shares jumped over 15% on Tuesday after Raymond James maintained an Outperform rating on the stock and raised its price target from $8 to $10.
    • Zovio Inc (NASDAQ:ZVO) fell 7.4% to $0.1808 in pre-market trading.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) fell 6.8% to $0.2369 in pre-market trading. AcelRx Pharmaceuticals, last month, posted a Q2 loss of $0.06 per share.
    • Sunrun Inc. (NASDAQ:RUN) fell 5.3% to $32.60 in pre-market trading after dropping 7% on Tuesday.
    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $AGRI
    $AIM
    $AMPE

    CompanyDatePrice TargetRatingAnalyst
    Sunrun Inc.
    $RUN
    1/13/2026Mkt Perform
    Raymond James
    Vistagen Therapeutics Inc.
    $VTGN
    12/17/2025$0.90Buy → Hold
    Jefferies
    Vistagen Therapeutics Inc.
    $VTGN
    12/17/2025Buy → Hold
    Maxim Group
    Vistagen Therapeutics Inc.
    $VTGN
    12/17/2025Outperform → Mkt Perform
    William Blair
    Vistagen Therapeutics Inc.
    $VTGN
    12/17/2025$1.00Buy → Hold
    Stifel
    Sunrun Inc.
    $RUN
    11/10/2025$27.00Neutral → Buy
    Guggenheim
    Sunrun Inc.
    $RUN
    11/7/2025$22.00 → $23.00Buy
    TD Cowen
    Sunrun Inc.
    $RUN
    10/21/2025$26.00Neutral → Buy
    Citigroup
    More analyst ratings

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Sunrun

    Raymond James initiated coverage of Sunrun with a rating of Mkt Perform

    1/13/26 9:17:53 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    VistaGen downgraded by Jefferies with a new price target

    Jefferies downgraded VistaGen from Buy to Hold and set a new price target of $0.90

    12/17/25 2:23:33 PM ET
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VistaGen downgraded by Maxim Group

    Maxim Group downgraded VistaGen from Buy to Hold

    12/17/25 12:23:57 PM ET
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AGRI
    $AIM
    $AMPE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACRX
    $AGRI
    $AIM
    $AMPE
    SEC Filings

    View All

    SEC Form ABS-15G filed by Sunrun Inc.

    ABS-15G - Sunrun Inc. (0001469367) (Filer)

    4/21/26 5:04:39 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form ABS-15G filed by Sunrun Inc.

    ABS-15G - Sunrun Inc. (0001469367) (Securitizer)

    4/21/26 5:03:30 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    SOBR Safe Inc. filed SEC Form 8-K: Other Events

    8-K - SOBR Safe, Inc. (0001425627) (Filer)

    4/17/26 4:15:45 PM ET
    $SOBR
    Newspapers/Magazines
    Consumer Discretionary

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pagaya Closes $500 Million AAA-Rated Auto ABS Transaction; Demonstrating Continued Investor Confidence

    RPM-2026-2 is the largest Auto ABS deal in Pagaya's history More than $3.5 billion of capital raised year-to-date to fund all asset classes in Pagaya's ABS program Pagaya Technologies LTD. (NASDAQ:PGY) ("Pagaya" or the "Company"), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced the closing of RPM-2026-2, a $500 million auto asset-backed securitization (ABS). Pagaya's RPM shelf, now in its seventh year, continues to be a trusted source of high-quality collateral serviced by the country's top auto lenders. "The successful execution of RPM-2026-2 is a testament to the trust we've built within the investment community over

    4/24/26 8:30:00 AM ET
    $PGY
    Finance: Consumer Services
    Finance

    Getty Images to Release First Quarter 2026 Financial Results on May 11, 2026

    NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. ("Getty Images") (NYSE:GETY), a preeminent global visual content creator and marketplace, announced today that the Company intends to release its first quarter 2026 results after market close on Monday, May 11, 2026, followed by a conference call at 4:30 p.m. (Eastern Time) that same day to discuss the Company's results. The conference call can be accessed live over the phone by dialing 1-800-245-3047, or for international callers, 1-203-518-9765. The conference ID for the call is GETTYQ1. An audio replay will be available for two weeks following the call and can be accessed by dialing 1-844-512-2921, or for internat

    4/22/26 4:07:00 PM ET
    $GETY
    Real Estate

    Smith Micro Schedules Teleconference to Announce First Quarter 2026 Financial Results

    Smith Micro Software, Inc. (NASDAQ:SMSI) announced that it will report its first quarter 2026 financial results following the close of regular trading on Wednesday, April 29, 2026. The news release will be followed by a teleconference available to all interested parties at 4:30 pm ET / 1:30 pm PT. The Smith Micro first quarter conference call may be accessed as follows: Date and Time: Wednesday, April 29, 2026 at 4:30 pm ET / 1:30 pm PT News Release: Available in Smith Micro's Newsroom Teleconference: Dial 1-844-701-1164 ten minutes before the start of the call. International participants can call 1-412-317-5492 A passcode is not required to access the teleconference. Ask the oper

    4/22/26 4:01:00 PM ET
    $SMSI
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Das Sanjiv

    4/A - Pagaya Technologies Ltd. (0001883085) (Issuer)

    4/20/26 4:45:33 PM ET
    $PGY
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Rosen Tami

    4 - Pagaya Technologies Ltd. (0001883085) (Issuer)

    4/20/26 4:29:45 PM ET
    $PGY
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Steele Jeanna

    4 - Sunrun Inc. (0001469367) (Issuer)

    4/14/26 4:48:51 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ferber Alan bought $149,029 worth of shares (12,500 units at $11.92), increasing direct ownership by 19% to 77,134 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    3/4/26 4:06:55 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Director Welch David Ryan was granted 97,410 shares and bought $1,424 worth of shares (11 units at $129.42), increasing direct ownership by 647% to 97,421 units (SEC Form 4)

    4 - AGRIFORCE GROWING SYSTEMS LTD. (0001826397) (Issuer)

    9/30/25 7:56:59 PM ET
    $AGRI
    Metal Fabrications
    Industrials

    Director Fenster Edward Harris bought $543,500 worth of shares (50,000 units at $10.87), increasing direct ownership by 4% to 1,408,182 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    5/13/25 7:57:16 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Financials

    Live finance-specific insights

    View All

    Getty Images to Release First Quarter 2026 Financial Results on May 11, 2026

    NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. ("Getty Images") (NYSE:GETY), a preeminent global visual content creator and marketplace, announced today that the Company intends to release its first quarter 2026 results after market close on Monday, May 11, 2026, followed by a conference call at 4:30 p.m. (Eastern Time) that same day to discuss the Company's results. The conference call can be accessed live over the phone by dialing 1-800-245-3047, or for international callers, 1-203-518-9765. The conference ID for the call is GETTYQ1. An audio replay will be available for two weeks following the call and can be accessed by dialing 1-844-512-2921, or for internat

    4/22/26 4:07:00 PM ET
    $GETY
    Real Estate

    Smith Micro Schedules Teleconference to Announce First Quarter 2026 Financial Results

    Smith Micro Software, Inc. (NASDAQ:SMSI) announced that it will report its first quarter 2026 financial results following the close of regular trading on Wednesday, April 29, 2026. The news release will be followed by a teleconference available to all interested parties at 4:30 pm ET / 1:30 pm PT. The Smith Micro first quarter conference call may be accessed as follows: Date and Time: Wednesday, April 29, 2026 at 4:30 pm ET / 1:30 pm PT News Release: Available in Smith Micro's Newsroom Teleconference: Dial 1-844-701-1164 ten minutes before the start of the call. International participants can call 1-412-317-5492 A passcode is not required to access the teleconference. Ask the oper

    4/22/26 4:01:00 PM ET
    $SMSI
    Computer Software: Prepackaged Software
    Technology

    Paysafe to Release First Quarter 2026 Earnings Results on May 13, 2026

    Paysafe Limited (NYSE:PSFE), a global payments platform, will announce first quarter 2026 financial results on Wednesday, May 13, 2026, before market open. Management will host a live webcast to discuss the results at 8:30 a.m. ET the same day. The webcast, along with supplemental information, can be accessed on the investor relations section of the Paysafe website at ir.paysafe.com. An archive will be available after the conclusion of the event and will remain available via the same link for at least one year. Webcast and Conference Call Information: Time: Wednesday, May 13, 2026, at 8:30 a.m. ET Webcast: Go to the Investor Relations section of the Paysafe w

    4/22/26 8:30:00 AM ET
    $PSFE
    Real Estate

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Leadership Updates

    Live Leadership Updates

    View All

    Smith Micro Announces Tim Huffmyer to Succeed Bill Smith as President and CEO

    Smith Micro Software, Inc. (NASDAQ:SMSI) today announced that it has named current Chief Operating Officer and Chief Financial Officer Tim Huffmyer to serve as Smith Micro's next President and Chief Executive Officer. Huffmyer will assume the role from Bill Smith, who has been appointed to the role of Executive Chairman. The changes will take effect on March 31, 2026 and follow leadership succession planning led by Smith and the Company's Board of Directors. "This planned leadership transition reflects the Board's ongoing succession planning and commitment to continuity in leadership and disciplined execution," said Smith. "With Tim's demonstrated strategic, financial and operational perf

    3/4/26 4:03:00 PM ET
    $SMSI
    Computer Software: Prepackaged Software
    Technology

    Paysafe Announces Changes to its Board of Directors

    New appointments bring deep expertise in global payments, digital transformation, marketing, and product innovation Paysafe (NYSE:PSFE), a leading payments platform, today announced the appointment of four new non‑executive directors to its Board, effective February 26, 2026. The new directors bring extensive expertise across global payments, financial services, technology, product innovation, and marketing leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227922419/en/Rupert Keeley Rupert Keeley Rupert Keeley brings significant strategic payments expertise and global regulatory insight to Paysafe. His decades of

    2/27/26 7:00:00 AM ET
    $PSFE
    Real Estate

    Vistagen Appoints Nick Tressler as Chief Financial Officer

    Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Nick Tressler as Chief Financial Officer (CFO), effective today, December 1, 2025. "I am excited to welcome Nick to Vistagen as our CFO. His financial and strategic acumen and extensive operational experience in the biopharmaceutical industry will be instrumental as we accelerate into our next phase," said President and Chief Executive Officer of Vistagen, Shawn Singh. "I look forward to his contributions to our leadership team and the po

    12/1/25 8:30:00 AM ET
    $AZN
    $SENS
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $ACRX
    $AGRI
    $AIM
    $AMPE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Paysafe Limited

    SC 13D/A - Paysafe Ltd (0001833835) (Subject)

    11/25/24 5:15:35 PM ET
    $PSFE
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Getty Images Holdings Inc.

    SC 13D/A - Getty Images Holdings, Inc. (0001898496) (Subject)

    11/22/24 5:10:10 PM ET
    $GETY
    Real Estate